FDA MedWatch - Freedom Driver System by SynCardia: Class I Recall - Part May Fail Causing Device to Stop Working

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Freedom Driver System by SynCardia: Class I Recall - Part May Fail Causing Device to Stop Working
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

 

Freedom Driver System by SynCardia: Class I Recall - Part May Fail Causing Device to Stop Working

AUDIENCE: Risk Manager, Surgery, Cardiology

ISSUE: FDA notified healthcare professionals of a Class I Recall of the Freedom Driver Systems used with the SynCardia temporary Total Artificial Heart (TAH-t). A specific part of the Freedom Driver drive mechanism may fail and cause the device to stop pumping. Patients do not receive any advanced warning that the device may fail. If it does fail, a red light located in the center of the driver, towards the top, will stay red and a loud continuous alarm will sound.

However, if the Freedom Driver stops pumping, the patient will lose consciousness almost immediately, which means that the warning light and alarm may not be helpful. The patient will likely experience serious injury or death if not immediately switched to a backup driver by a caregiver.

See the FDA Class I Recall Notice for a listing of affected lot/serial numbers.

BACKGROUND: The SynCardia Total Artificial Heath (TAH-t) is a mechanical replacement for a patient’s heart. It is a pump that is implanted into the chest to replace the bottom half of a patient's heart (left and right ventricles). The device is sewn to the remaining top half of the patient's heart (atria). The Freedom Driver System is attached to the TAH-t pump and operates and monitors the device.

RECOMMENDATION: On August 6, 2015, SynCardia Systems sent an Urgent Medical Device Recall letter to their customers. SynCardia told customers they will notify all hospitals that have the affected drivers and replace the drivers with new ones. Additionally, SynCardia informed customers to:

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch Safety Alert, including a link to the Class I Recall Notice, at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm463318.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux